876 related articles for article (PubMed ID: 27659097)
21. Role of cAMP-phosphodiesterase 1C signaling in regulating growth factor receptor stability, vascular smooth muscle cell growth, migration, and neointimal hyperplasia.
Cai Y; Nagel DJ; Zhou Q; Cygnar KD; Zhao H; Li F; Pi X; Knight PA; Yan C
Circ Res; 2015 Mar; 116(7):1120-32. PubMed ID: 25608528
[TBL] [Abstract][Full Text] [Related]
22. Deficiency of MAPK-activated protein kinase 2 (MK2) prevents adverse remodelling and promotes endothelial healing after arterial injury.
Kapopara PR; von Felden J; Soehnlein O; Wang Y; Napp LC; Sonnenschein K; Wollert KC; Schieffer B; Gaestel M; Bauersachs J; Bavendiek U
Thromb Haemost; 2014 Dec; 112(6):1264-76. PubMed ID: 25120198
[TBL] [Abstract][Full Text] [Related]
23. Kalirin promotes neointimal hyperplasia by activating Rac in smooth muscle cells.
Wu JH; Fanaroff AC; Sharma KC; Smith LS; Brian L; Eipper BA; Mains RE; Freedman NJ; Zhang L
Arterioscler Thromb Vasc Biol; 2013 Apr; 33(4):702-8. PubMed ID: 23288169
[TBL] [Abstract][Full Text] [Related]
24. Dedicator of cytokinesis 2, a novel regulator for smooth muscle phenotypic modulation and vascular remodeling.
Guo X; Shi N; Cui XB; Wang JN; Fukui Y; Chen SY
Circ Res; 2015 May; 116(10):e71-80. PubMed ID: 25788409
[TBL] [Abstract][Full Text] [Related]
25. Surfactant Protein A, a Novel Regulator for Smooth Muscle Phenotypic Modulation and Vascular Remodeling-Brief Report.
Ran R; Cai D; King SD; Que X; Bath JM; Chen SY
Arterioscler Thromb Vasc Biol; 2021 Feb; 41(2):808-814. PubMed ID: 33267655
[TBL] [Abstract][Full Text] [Related]
26. Olfactomedin 2 Regulates Smooth Muscle Phenotypic Modulation and Vascular Remodeling Through Mediating Runt-Related Transcription Factor 2 Binding to Serum Response Factor.
Shi N; Li CX; Cui XB; Tomarev SI; Chen SY
Arterioscler Thromb Vasc Biol; 2017 Mar; 37(3):446-454. PubMed ID: 28062493
[TBL] [Abstract][Full Text] [Related]
27. Carvacrol inhibits atherosclerotic neointima formation by downregulating reactive oxygen species production in vascular smooth muscle cells.
Lee KP; Sudjarwo GW; Jung SH; Lee D; Lee DY; Lee GB; Baek S; Kim DY; Lee HM; Kim B; Kwon SC; Won KJ
Atherosclerosis; 2015 Jun; 240(2):367-73. PubMed ID: 25875388
[TBL] [Abstract][Full Text] [Related]
28. Uncoupling Protein 2 Inhibits Myointimal Hyperplasia in Preclinical Animal Models of Vascular Injury.
Zhang Y; Zhang Y; Li W; Wang P; Gu R; Feng Y; Wei S; Peng K; Zhang Y; Su L; Wang Q; Li D; Yang D; Wong WT; Yang Y; Ma S
J Am Heart Assoc; 2017 Oct; 6(10):. PubMed ID: 29025747
[TBL] [Abstract][Full Text] [Related]
29. Downregulation of Cavin-1 Expression via Increasing Caveolin-1 Degradation Prompts the Proliferation and Migration of Vascular Smooth Muscle Cells in Balloon Injury-Induced Neointimal Hyperplasia.
Zhou LJ; Chen XY; Liu SP; Zhang LL; Xu YN; Mu PW; Geng DF; Tan Z
J Am Heart Assoc; 2017 Jul; 6(8):. PubMed ID: 28751541
[TBL] [Abstract][Full Text] [Related]
30. Cathepsin S Activity Controls Injury-Related Vascular Repair in Mice via the TLR2-Mediated p38MAPK and PI3K-Akt/p-HDAC6 Signaling Pathway.
Wu H; Cheng XW; Hu L; Takeshita K; Hu C; Du Q; Li X; Zhu E; Huang Z; Yisireyili M; Zhao G; Piao L; Inoue A; Jiang H; Lei Y; Zhang X; Liu S; Dai Q; Kuzuya M; Shi GP; Murohara T
Arterioscler Thromb Vasc Biol; 2016 Aug; 36(8):1549-57. PubMed ID: 27365406
[TBL] [Abstract][Full Text] [Related]
31. The cyclolignan picropodophyllin attenuates intimal hyperplasia after rat carotid balloon injury by blocking insulin-like growth factor-1 receptor signaling.
Razuvaev A; Henderson B; Girnita L; Larsson O; Axelson M; Hedin U; Roy J
J Vasc Surg; 2007 Jul; 46(1):108-15. PubMed ID: 17606126
[TBL] [Abstract][Full Text] [Related]
32. Recombinant plasminogen activator inhibitor-1 inhibits intimal hyperplasia.
Wu J; Peng L; McMahon GA; Lawrence DA; Fay WP
Arterioscler Thromb Vasc Biol; 2009 Oct; 29(10):1565-70. PubMed ID: 19574558
[TBL] [Abstract][Full Text] [Related]
33. Redox-sensitive transcription factor Nrf2 regulates vascular smooth muscle cell migration and neointimal hyperplasia.
Ashino T; Yamamoto M; Yoshida T; Numazawa S
Arterioscler Thromb Vasc Biol; 2013 Apr; 33(4):760-8. PubMed ID: 23413426
[TBL] [Abstract][Full Text] [Related]
34. Truncated YY1 interacts with BASP1 through a 339KLK341 motif in YY1 and suppresses vascular smooth muscle cell growth and intimal hyperplasia after vascular injury.
Santiago FS; Li Y; Zhong L; Raftery MJ; Lins L; Khachigian LM
Cardiovasc Res; 2021 Sep; 117(11):2395-2406. PubMed ID: 33508088
[TBL] [Abstract][Full Text] [Related]
35. Plasminogen activator inhibitor-1 and vitronectin expression level and stoichiometry regulate vascular smooth muscle cell migration through physiological collagen matrices.
Garg N; Goyal N; Strawn TL; Wu J; Mann KM; Lawrence DA; Fay WP
J Thromb Haemost; 2010 Aug; 8(8):1847-54. PubMed ID: 20492459
[TBL] [Abstract][Full Text] [Related]
36. Recombinant soluble apyrase APT102 inhibits thrombosis and intimal hyperplasia in vein grafts without adversely affecting hemostasis or re-endothelialization.
Ji Y; Adeola O; Strawn TL; Jeong SS; Chen R; Fay WP
J Thromb Haemost; 2017 Apr; 15(4):814-825. PubMed ID: 28079982
[TBL] [Abstract][Full Text] [Related]
37. A small molecule PAI-1 functional inhibitor attenuates neointimal hyperplasia and vascular smooth muscle cell survival by promoting PAI-1 cleavage.
Simone TM; Higgins SP; Archambeault J; Higgins CE; Ginnan RG; Singer H; Higgins PJ
Cell Signal; 2015 May; 27(5):923-33. PubMed ID: 25617690
[TBL] [Abstract][Full Text] [Related]
38. The inflammatory cytokine oncostatin M induces PAI-1 in human vascular smooth muscle cells in vitro via PI 3-kinase and ERK1/2-dependent pathways.
Demyanets S; Kaun C; Rychli K; Rega G; Pfaffenberger S; Afonyushkin T; Bochkov VN; Maurer G; Huber K; Wojta J
Am J Physiol Heart Circ Physiol; 2007 Sep; 293(3):H1962-8. PubMed ID: 17604327
[TBL] [Abstract][Full Text] [Related]
39. Macrophage Notch Ligand Delta-Like 4 Promotes Vein Graft Lesion Development: Implications for the Treatment of Vein Graft Failure.
Koga JI; Nakano T; Dahlman JE; Figueiredo JL; Zhang H; Decano J; Khan OF; Niida T; Iwata H; Aster JC; Yagita H; Anderson DG; Ozaki CK; Aikawa M
Arterioscler Thromb Vasc Biol; 2015 Nov; 35(11):2343-2353. PubMed ID: 26404485
[TBL] [Abstract][Full Text] [Related]
40. Fibrillar collagen regulation of plasminogen activator inhibitor-1 is involved in altered smooth muscle cell migration.
Tanaka S; Koyama H; Ichii T; Shioi A; Hosoi M; Raines EW; Nishizawa Y
Arterioscler Thromb Vasc Biol; 2002 Oct; 22(10):1573-8. PubMed ID: 12377732
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
